Quality Policy
Develop clinically effective, innovative and affordable Transdermal therapeutic products to improve the quality of life of patients in need of such therapies.
Our products are to meet international standards of quality.
Read more
Manufacturing Facilities
Production of various types of patches. Quality control is capable of analyzing pharmaceutical raw materials as well as finished transdermal products.
Open to discuss contract manufacturing services globally
Read moreSparsha Pharma International
Sparsha Pharma International Pvt. Ltd. (Sparsha Pharma) is the pioneer in Transdermal Drug Delivery Systems (TDDS) in India and the first Transdermal Patch manufacturing company in India. TDDS is a relatively novel drug delivery system in which the drug is delivered into the body through the skin by means of applying a patch formulation, which has proven to have great advantages over the conventional dosage forms like:
-
Improved bioavailability by avoiding first pass metabolism; - Ensure a consistent drug concentration in the bloodstream
- Better Patient compliance
- Easy to apply and easy to terminate the dose.
Our Products
SERVICES
- Sparsha Pharma satisfies a wide range of production and approval needs with fully integrated testing capabilities, thanks to the rigour of our testing and analysis services as well as the benefits of full-service made available in manufacturing.
- Both large and small businesses rely on our expertise at every stage of formulation, development, and manufacturing.
- Powered by Transdermal Matrix technology, our 24-hour Lidocaine patch delivers superior performance and enhanced efficiency, outperforming other bulkier and conventional hydrogel alternatives.
Sparsha Pharma International Pvt. Ltd.
is India’s First Transdermal Drug Delivery Company (2008)
Engaged in the Research & Development, Manufacturing and Marketing of Transdermal products. Contribute to the wellbeing of patients through...
- Innovative
- Safe
- Effective
- Affordable transdermal products across the globe.